Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
740 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute at University of Alberta
Edmonton, Alberta, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Ottawa Hospital Regional Cancer Centre - General Campus
Ottawa, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Toronto Sunnybrook Regional Cancer Centre at Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Women'S College Ambulatory Care Center at Sunnybrook and Women'S College Health Science Center
Toronto, Ontario, Canada
- Chum Hopital Saint-Luc
Montreal, Quebec, Canada
- Hopital Notre-Dame Du Chum
Montreal, Quebec, Canada
- Hotel Dieu de Montreal
Montreal, Quebec, Canada
- Montreal General Hospital
Montreal, Quebec, Canada
- Royal Victoria Hospital - Montreal
Montreal, Quebec, Canada
- Hopital Du Saint-Sacrement, Quebec
Québec, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- Andres Grillasca Hospital
Ponce, Puerto Rico
- Hato Rey Hematology/oncology Group
San Juan, Puerto Rico
- San Juan City Hospital
San Juan, Puerto Rico
- Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
- Comprehensive Cancer Center at University of Alabama at Birmingham
Birmingham, Alabama, United States
- Huntsville Hospital
Huntsville, Alabama, United States
- Mobile Infirmary Medical Center
Mobile, Alabama, United States
- East Alabama Medical Center
Opelika, Alabama, United States
- Cancer Center at Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Banner Thunderbird Medical Center
Glendale, Arizona, United States
- Banner Good Samaritan Medical Center
Phoenix, Arizona, United States
- Ccop - Western Regional, Arizona
Phoenix, Arizona, United States
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
- Saint Joseph'S Mercy Cancer Center
Hot Springs, Arkansas, United States
- Alta Bates Comprehensive Cancer Center
Berkeley, California, United States
- Providence Saint Joseph Medical Center - Burbank
Burbank, California, United States
- Peninsula Medical Center
Burlingame, California, United States
- Mount Diablo Regional Cancer Center
Concord, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- North Bay Cancer Center
Fairfield, California, United States
- Kaiser Permanente - Fremont
Fremont, California, United States
- Washington Township Hospital
Fremont, California, United States
- California Cancer Center - Woodward Park Office
Fresno, California, United States
- Virginia K. Crosson Cancer Center at St. Jude Medical Center
Fullerton, California, United States
- Glendale Memorial Hospital Comprehensive Cancer Center
Glendale, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2003
- Primary completion
- 31 Mar 2015
- Completion
- 31 May 2016
- Last update posted
- 20 Sept 2018
- Registered enrollment
- 3,104
- Registry id
- NCT00053898
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.